| Literature DB >> 34066337 |
Felipe Mozo-Alonso1, José P Novalbos-Ruiz2, Juan C Duran-Alonso3, Amelia Rodríguez-Martin4.
Abstract
BACKGROUND: A significant increase in the prevalence of malnourishment, obesity, and sarcopenic obesity has been observed in developed countries over the last few decades. In Spain, this especially happens in populations over 65 who are not institutionalized. Differences in lifestyle, medication, and economic capacity partially explain this increase.Entities:
Keywords: elderly; nutritional status; obesity; overweight; physical activity; polypharmacy
Year: 2021 PMID: 34066337 PMCID: PMC8148168 DOI: 10.3390/nu13051561
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
General characteristics of non-institutionalized aged 65s or over: Economic contribution pharmacy expenses, dietary habits, physical activity or a sedentary lifestyle, polypharmacy. PYSMA Study.
| Men | Women | |||||
|---|---|---|---|---|---|---|
|
| % |
| % | |||
| 1000 | 38.2% | 1621 | 61.8% | |||
| Age Group (years) | 65–69 | 251 | 25.1% | 486 | 30.0% | 0.006 * |
| 70–74 | 261 | 26.1% | 447 | 27.6% | ||
| 75–79 | 217 | 21.7% | 340 | 21.0% | ||
| 80–84 | 186 | 18.6% | 247 | 15.2% | ||
| ≥85 | 85 | 8.5% | 101 | 6.2% | ||
| Economic Allowance—Economic Contribution Pharmacy Expenses | TSI01 < 18.000€—0% | 68 | 7.0% | 154 | 9.9% | 0.011 * |
| TSI02 < 18.000€—10% | 763 | 78.7% | 1239 | 79.3% | ||
| TSI02B 18–100.000€—10% | 71 | 7.3% | 85 | 5.4% | ||
| TSI06B Work Insurance—30% | 56 | 5.8% | 76 | 4.9% | ||
| TSI05 > 100.000€—60% | 12 | 1.2% | 9 | 0.6% | ||
| Variety Food Main Meals | Full breakfast | 92 | 10.2% | 189 | 12.7% | 0.166 * |
| Complete lunch | 733 | 79.0% | 1231 | 81.4% | 0.104 * | |
| Complete dinner | 403 | 43.8% | 630 | 42.1% | 0.421 ** | |
| Physical Activity | Sedentary lifestyle | 149 | 15.4% | 316 | 20.2% | 0.000 * |
| Light (walk) | 507 | 52.3% | 896 | 57.3% | ||
| Moderate (1–3 days/week) | 213 | 22.0% | 267 | 17.1% | ||
| Intense (>3 days/week) | 101 | 10.4% | 84 | 5.4% | ||
| Polypharmacy and Drug Consumption Frequency | 5 or more drugs | 531 | 54.7% | 868 | 55.5% | 0.712 ** |
| Anxiolytics | 223 | 23.0% | 617 | 39.5% | 0.000 ** | |
| Antidepressants | 113 | 11.6% | 363 | 23.2% | 0.000 ** | |
| Anxiolytics+antidepressants | 68 | 6.8% | 242 | 14.9% | 0.000 * | |
| Antiparkinsonians | 45 | 4.6% | 141 | 9.0% | 0.000 ** | |
* p value Chi-square test; ** p value Fisher’s exact test.
BMI percentiles according to age group and gender.
| Percentiles | Men ( | ||||
|---|---|---|---|---|---|
| 65–69 years | 70–74 years | 75–79 years | 80–84 years | ≥85 years | |
| P5 | 22.83 | 21.99 | 23.01 | 22.56 | 21.79 |
| P10 | 23.97 | 24.11 | 23.81 | 24.08 | 22.79 |
| P25 | 26.05 | 26.01 | 25.70 | 25.76 | 25.03 |
| P50 | 28.87 | 28.31 | 28.04 | 28.28 | 28.27 |
| P75 | 31.93 | 31.12 | 30.10 | 30.85 | 31.07 |
| P90 | 34.77 | 33.45 | 33.23 | 33.41 | 33.68 |
| P95 | 37.05 | 35.26 | 34.99 | 34.97 | 35.47 |
|
| |||||
|
|
|
|
|
| |
| P5 | 21.57 | 22.31 | 22.05 | 22.27 | 19.48 |
| P10 | 22.83 | 23.93 | 23.48 | 23.71 | 21.83 |
| P25 | 25.80 | 26.28 | 26.05 | 25.63 | 25.14 |
| P50 | 29.02 | 29.38 | 29.77 | 28.93 | 28.03 |
| P75 | 32.58 | 32.64 | 32.38 | 32.31 | 30.19 |
| P90 | 36.69 | 36.29 | 35.47 | 35.20 | 34.52 |
| P95 | 38.82 | 39.26 | 37.86 | 37.20 | 35.81 |
Background color indicate BMI < 25 in green or BMI > 30 in red.
BMI distribution according to age group and gender.
| BMI | |||||
|---|---|---|---|---|---|
| Age Group | <18.5 | 18.5–24.9 | 25–29.9 | ≥30 | |
| Underweight | Normalweight | Overweight | Obesity | ||
| MEN | 65–69 | 16.7% | 40.2% | 43.0% | |
| 70–74 | 0.8% | 13.8% | 52.5% | 33.0% | |
| 75–79 | 0.5% | 18.4% | 55.8% | 25.3% | |
| 80–84 | 0.5% | 16.1% | 49.5% | 33.9% | |
| ≥85 | 24.7% | 47.1% | 28.2% | ||
| All groups | 0.4% | 16.9% | 49.1% | 33.6% | |
| WOMEN | 65–69 | 0.2% | 18.9% | 40.5% | 40.3% |
| 70–74 | 0.4% | 14.5% | 40.7% | 44.3% | |
| 75–79 | 0.3% | 16.5% | 35.3% | 47.9% | |
| 80–84 | 21.1% | 38.1% | 40.9% | ||
| ≥85 | 2.0% | 22.8% | 48.5% | 26.7% | |
| All groups | 0.4% | 17.8% | 39.6% | 42.3% | |
Level of physical activity, variety of food groups in main meals, and polypharmacy in adults aged 65 years old and over in rural, semi-urban, and urban areas. PYSMA Study.
| Types of Cities | ||||
|---|---|---|---|---|
| Rural | Semi-Urban | Urban | Total | |
| Level of physical activity | ||||
| Sedentary lifestyle | 13.4% * | 23.80% | 17.80% | 18.50% |
| Light physical activity (walk) | 55.10% | 53.50% | 55.90% | 55.40% |
| Moderate physical activity (1–3 days/week) | 21.8% * | 16.70% | 19.00% | 18.80% |
| Intense physical activity (>3 days/week) | 9.70% | 6.00% | 7.30% | 7.30% |
| Variety of food groups main meals | ||||
| Full breakfast | 8.00% | 11.40% | 12.20% | 11.70% |
| Complete lunch | 79.20% | 78.80% | 81.10% | 80.60% |
| Complete dinner | 45.00% | 44.20% | 42.10% | 42.70% |
| Polypharmacy | 63.0% φ | 55.80% | 54.40% | 55.40% |
| (5 or more drugs) | ||||
* T-Kendall 2.45 p = 0.014; φ Fisher’s exact test p = 0.022.
Figure 1Nutritional status according to antidepressants or anxiolytic drugs use.
Factors associated with the presence of overweight and obesity among non-institutionalized adults aged 65 years old and over. Multivariate analysis.
| 95% C.I. EXP(B) | ||||||
|---|---|---|---|---|---|---|
| B | Standard Error | Exp(B) | Low | High | ||
| SEX | 0.114 | 0.114 | 0.316 | 1.121 | 0.897 | 1.400 |
| AGE GROUPS | 0.001 | |||||
| 65–69 years | 0.719 | 0.206 | 0.000 | 2.053 | 1.372 | 3.071 |
| 70–74 years | 0.846 | 0.208 | 0.000 | 2.331 | 1.550 | 3.506 |
| 75–79 years | 0.544 | 0.210 | 0.009 | 1.722 | 1.142 | 2.597 |
| 80–84 years | 0.457 | 0.217 | 0.035 | 1.579 | 1.032 | 2.416 |
| ECONOMIC CONTRIBUTION PHARMACY EXPENSES (TS) | −0.175 | 0.080 | 0.028 | 0.839 | 0.717 | 0.982 |
| PHYSICAL ACTIVITY LEVEL | 0.026 | |||||
| Sedentary lifestyle | 0.475 | 0.236 | 0.044 | 1.608 | 1.012 | 2.553 |
| Light physical activity (walk) | 0.321 | 0.201 | 0.109 | 1.379 | 0.931 | 2.043 |
| Moderate physical activity (1–3 days/week) | 0.007 | 0.217 | 0.974 | 1.007 | 0.659 | 1.540 |
| FOOD VARIETY IN DINNER | 0.248 | 0.109 | 0.023 | 1.281 | 1.034 | 1.586 |
| POLIPHARMACY | 0.285 | 0.112 | 0.011 | 1.330 | 1.068 | 1.657 |
| Constant | 1.005 | 0.324 | 0.002 | 2.733 | ||